FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081569081> ?p ?o ?g. }

• W2081569081 endingPage "281" @default.
• W2081569081 startingPage "273" @default.
• W2081569081 abstract "Ezrin is a membrane-cytoskeleton linker protein, which regulates cell polarity and signaling. Increased ezrin expression in astrocytomas and uveal melanomas is correlated with unfavorable prognostic factors and reduced patient survival. We investigated ezrin IR in normal ovarian surface epithelium and serous ovarian carcinomas, and its relation with clinical parameters and patient outcome.Tissue microarray blocks were constructed of all serous ovarian carcinoma tissue samples removed at a primary operation in Helsinki University Central Hospital between 1964 and 1999 and of healthy ovarian tissue samples. Ezrin expression was assessed by indirect immunohistochemistry using a monoclonal 3C12 ezrin antibody. Tissue samples (n = 440) were scored for the intensity of ezrin immunoreactivity, and the scores were compared with patient age, the stage and grade of disease, and disease outcome.Healthy ovarian epithelium showed strong polarized ezrin immunoreactivity. In serous ovarian carcinoma, the reactivity varied from strong (15.0% of samples) to moderate (57.3%) or weak/negative (27.7%) and the subcellular distribution was typically diffuse. Weak or negative expression of ezrin was associated with shorter survival (P = 0.027) but also with an advanced age of the patients (P = 0.0001), and a higher histological grade of the disease (P = 0.032). In Cox multivariate survival analysis, ezrin immunoreactivity had no independent effect on survival, when controlling for the stage and grade of the disease, and patient age.In contrast with astrocytomas and uveal melanomas, negative or weak ezrin immunoreactivity in serous ovarian carcinoma correlates with poor patient outcome." @default.
• W2081569081 created "2016-06-24" @default.
• W2081569081 creator A5004114938 @default.
• W2081569081 creator A5007248500 @default.
• W2081569081 creator A5010863055 @default.
• W2081569081 creator A5024623241 @default.
• W2081569081 creator A5029463204 @default.
• W2081569081 creator A5030148031 @default.
• W2081569081 date "2003-08-01" @default.
• W2081569081 modified "2023-10-05" @default.
• W2081569081 title "Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients" @default.
• W2081569081 cites W1995100228 @default.
• W2081569081 cites W1995811820 @default.
• W2081569081 cites W2003481815 @default.
• W2081569081 cites W2008207415 @default.
• W2081569081 cites W2036802726 @default.
• W2081569081 cites W2037503011 @default.
• W2081569081 cites W2041415289 @default.
• W2081569081 cites W2043610446 @default.
• W2081569081 cites W2044016667 @default.
• W2081569081 cites W2045559903 @default.
• W2081569081 cites W2052203427 @default.
• W2081569081 cites W2079681700 @default.
• W2081569081 cites W2087810003 @default.
• W2081569081 cites W2105567655 @default.
• W2081569081 cites W2122218045 @default.
• W2081569081 cites W2125492990 @default.
• W2081569081 cites W2134360487 @default.
• W2081569081 cites W2147469756 @default.
• W2081569081 cites W2148880541 @default.
• W2081569081 cites W2158430216 @default.
• W2081569081 doi "https://doi.org/10.1016/s0090-8258(03)00262-2" @default.
• W2081569081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12893187" @default.
• W2081569081 hasPublicationYear "2003" @default.
• W2081569081 type Work @default.
• W2081569081 sameAs 2081569081 @default.
• W2081569081 citedByCount "80" @default.
• W2081569081 countsByYear W20815690812012 @default.
• W2081569081 countsByYear W20815690812013 @default.
• W2081569081 countsByYear W20815690812014 @default.
• W2081569081 countsByYear W20815690812015 @default.
• W2081569081 countsByYear W20815690812016 @default.
• W2081569081 countsByYear W20815690812017 @default.
• W2081569081 countsByYear W20815690812019 @default.
• W2081569081 countsByYear W20815690812020 @default.
• W2081569081 countsByYear W20815690812021 @default.
• W2081569081 countsByYear W20815690812022 @default.
• W2081569081 countsByYear W20815690812023 @default.
• W2081569081 crossrefType "journal-article" @default.
• W2081569081 hasAuthorship W2081569081A5004114938 @default.
• W2081569081 hasAuthorship W2081569081A5007248500 @default.
• W2081569081 hasAuthorship W2081569081A5010863055 @default.
• W2081569081 hasAuthorship W2081569081A5024623241 @default.
• W2081569081 hasAuthorship W2081569081A5029463204 @default.
• W2081569081 hasAuthorship W2081569081A5030148031 @default.
• W2081569081 hasConcept C121608353 @default.
• W2081569081 hasConcept C126322002 @default.
• W2081569081 hasConcept C142669718 @default.
• W2081569081 hasConcept C142724271 @default.
• W2081569081 hasConcept C143998085 @default.
• W2081569081 hasConcept C1491633281 @default.
• W2081569081 hasConcept C150173356 @default.
• W2081569081 hasConcept C193270364 @default.
• W2081569081 hasConcept C204232928 @default.
• W2081569081 hasConcept C2777546739 @default.
• W2081569081 hasConcept C2777632260 @default.
• W2081569081 hasConcept C2780246058 @default.
• W2081569081 hasConcept C2780427987 @default.
• W2081569081 hasConcept C3019054536 @default.
• W2081569081 hasConcept C502942594 @default.
• W2081569081 hasConcept C54355233 @default.
• W2081569081 hasConcept C71924100 @default.
• W2081569081 hasConcept C86803240 @default.
• W2081569081 hasConceptScore W2081569081C121608353 @default.
• W2081569081 hasConceptScore W2081569081C126322002 @default.
• W2081569081 hasConceptScore W2081569081C142669718 @default.
• W2081569081 hasConceptScore W2081569081C142724271 @default.
• W2081569081 hasConceptScore W2081569081C143998085 @default.
• W2081569081 hasConceptScore W2081569081C1491633281 @default.
• W2081569081 hasConceptScore W2081569081C150173356 @default.
• W2081569081 hasConceptScore W2081569081C193270364 @default.
• W2081569081 hasConceptScore W2081569081C204232928 @default.
• W2081569081 hasConceptScore W2081569081C2777546739 @default.
• W2081569081 hasConceptScore W2081569081C2777632260 @default.
• W2081569081 hasConceptScore W2081569081C2780246058 @default.
• W2081569081 hasConceptScore W2081569081C2780427987 @default.
• W2081569081 hasConceptScore W2081569081C3019054536 @default.
• W2081569081 hasConceptScore W2081569081C502942594 @default.
• W2081569081 hasConceptScore W2081569081C54355233 @default.
• W2081569081 hasConceptScore W2081569081C71924100 @default.
• W2081569081 hasConceptScore W2081569081C86803240 @default.
• W2081569081 hasIssue "2" @default.
• W2081569081 hasLocation W20815690811 @default.
• W2081569081 hasLocation W20815690812 @default.
• W2081569081 hasOpenAccess W2081569081 @default.
• W2081569081 hasPrimaryLocation W20815690811 @default.
• W2081569081 hasRelatedWork W1969023321 @default.
• W2081569081 hasRelatedWork W2044237862 @default.

• next